YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DX25F6AGV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,227
Award facts
- Contract value 100% obligated
- $2,226.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a $2,226.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The delivery order, issued on September 22, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation and was awarded competitively. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award contract with a $499.999 billion ceiling value extending through December 31, 2036, which positions the company as a critical regional pharmaceutical supplier for Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a qualified supplier within the PPV-G GEN V acquisition strategy, which supports the broader $30.3 billion pharmaceutical procurement initiative for DoD. The company's comprehensive product portfolio spans branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals, enabling it to fulfill diverse medical supply requirements across military healthcare operations. This award reflects the company's consistent performance and competitive capability in unrestricted federal pharmaceutical procurement, as evidenced by numerous delivery orders issued throughout October 2025 ranging from under $100 to awards exceeding $115,000.
Quick answers
Who was awarded contract SPE2DX25F6AGV?
SPE2DX25F6AGV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2DX25F6AGV worth?
The government has obligated $2,227 on SPE2DX25F6AGV.
Is contract SPE2DX25F6AGV an order under another contract?
Yes. SPE2DX25F6AGV is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGV competed?
The extent of competition for SPE2DX25F6AGV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award